about
Omega-3 fatty acids: potential role in the management of early Alzheimer's diseaseAutism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisitedSevere cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UKNeuroendocrine hormone amylin in diabetesCerebral microinfarcts: the invisible lesionsPrediction of cognitive decline in healthy older adults using fMRIFunctional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adultsIdentification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional dataThe Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.Vascular pathology in the aged human brainIncreased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.Interaction of age and APOE genotype on cerebral blood flow at rest.Alterations in working memory as a function of leukoaraiosis in dementiaCo-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.Cardiac index is associated with brain aging: the Framingham Heart StudyGray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters.Cerebral microinfarcts: a systematic review of neuropathological studies.Family history and APOE-4 genetic risk in Alzheimer's disease.Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns.Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's diseaseVascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum.Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.Cerebrovascular disease pathology and parkinsonian signs in old age.APOE and mild cognitive impairment: the Framingham Heart StudyAPOEε2 is associated with milder clinical and pathological Alzheimer disease.Aberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriersCholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tanglesCognitive impact of subcortical vascular and Alzheimer's disease pathologyEffect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognitionThe APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and miceAntioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementiaPathology and pathogenesis of vascular cognitive impairment-a critical updateNeuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseAssociation of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer diseaseThe effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter HyperintensitiesPathogenesis and treatment of vascular cognitive impairment.
P2860
Q24595490-3EC0403A-7084-46FC-91E0-EBB4C52B0948Q24647915-A33FB734-3CA1-47E8-89CB-2DEF1276686CQ24678429-F55185C1-9EA3-4BB7-B1F6-79B2D996BF59Q26751000-06E12B0B-D378-453B-A2A1-47DAB0201608Q27026027-260A4C92-DD19-4A93-8BFC-94CE45B4F4E4Q28383378-2ADE5C88-0DAB-4919-B066-4F6B89011BC5Q28394313-75491385-A408-4DB7-B45E-2D450C5F8D6CQ30000273-6133C0FB-EF50-43E4-B334-6D7559C57011Q31048037-304431EF-BD61-4C04-9B0E-A949D3E84FF2Q31111440-DCCEAE56-2A82-4F85-8D38-CC2EA3E90B4CQ33699436-7C5A452B-95DE-4738-ADE3-BA3DFB325781Q33823353-E8E8C40B-1BF4-422B-AB9E-9126EA918FE7Q34014704-135B912D-B42B-4762-BC5A-1F8BBFD2BC87Q34024143-9B35749D-4B33-4B4C-B3CC-774404B730A2Q34039605-34E8DA0B-02F8-48E1-BEFD-5CA27DD8FD26Q34090309-712FC7BF-8789-4D89-B979-6C95EFD32526Q34098507-605EBAC5-DE74-406C-B5C5-F18BFCFAFD29Q34123278-B8D27FF7-5E97-408A-9232-31CF1C355F6FQ34167647-7B3918D2-812C-4D0C-927A-3CDF40B02E2EQ34212947-C7AFF2AC-EFCB-46F9-8ABB-925637E26F02Q35189449-7ADF2065-A4DC-46AD-87EF-FA2548A5E2C8Q35195389-05538242-E5A5-481C-A90B-55F76ABA9316Q35232491-9EBCADAF-6DD2-4232-8FF4-D00BDDF75F31Q35434368-408E64E2-0E23-401D-A07C-704FC7591374Q35448970-511F1F0F-79D1-4B98-B0F3-82288D84FBC2Q35452750-286FB5B3-2E00-4C6D-A33F-53AA6010E244Q35660968-EA7AE314-B92B-4411-B266-4A45931B8DE9Q35664370-DC1E6297-93AB-40E8-800B-7E454913E895Q35700985-528475C5-36A8-4D98-9D5D-4BFF10DF5407Q35750397-0F05FDC4-52A4-4350-9D70-B35F1C1623EBQ36170349-EF978AC8-4245-465E-8F1D-FBFC719ABB36Q36393038-17D39246-B120-47C7-93E7-6710924C4AA2Q36638605-19CD8363-8874-4286-A223-E6AFDCA7B263Q36754568-F6F23B39-6A22-4C03-9C67-86EC6B9E9EF0Q37180396-8CD8FB90-61BF-4E09-81E5-3F3F104005CEQ37208538-EA1A940B-A678-451A-AA8D-F0A53127AF93Q37286176-3B035679-CD03-416E-B763-CB51743F478AQ37364340-DDD58348-BC48-4624-9791-71B146F3B0E0Q37424440-C7C6898C-BFEF-47E0-9E0D-ED52B6A10D15Q38297016-853B7D40-70E1-491C-BDAC-9601AD49AD41
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
APOE, vascular pathology, and the AD brain.
@en
APOE, vascular pathology, and the AD brain.
@nl
type
label
APOE, vascular pathology, and the AD brain.
@en
APOE, vascular pathology, and the AD brain.
@nl
prefLabel
APOE, vascular pathology, and the AD brain.
@en
APOE, vascular pathology, and the AD brain.
@nl
P2093
P1433
P1476
APOE, vascular pathology, and the AD brain.
@en
P2093
P304
P356
10.1212/01.WNL.0000168863.49053.4D
P407
P577
2005-07-01T00:00:00Z